Back to search
FDAFDA · Food and drugs·Recall number Z-2483-2023

Oculus Pentacam AXL , Ref 70100, CE 0123

Published September 6, 2023 · Recall initiated: August 8, 2023

Summary

FDA records medical device Class II recall Z-2483-2023, published September 6, 2023 and initiated August 8, 2023. Recalling firm: Oculus Optikgeraete GMBH; Status: Ongoing; Reported quantity: 364 units; Lot: UDI-DI; (01) 04049584012333. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Their is a potential that optical devices with insufficient anti-reflective coating may lead to incorrect axial length measurements.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Oculus Optikgeraete GMBH
Distributor
US Nationwide distribution in the states of CA, FL, MA, MN, NY, NC, OH, PA, TX, VA, WA. OUS: Not Provided
Lot
UDI-DI; (01) 04049584012333
Risk classification
Class II
Area (FDA)
device
Country
Germany

Related recalls

Questions about this recall

Was Oculus Pentacam AXL , Ref 70100, CE 0123 recalled?

Yes. FDA published recall Z-2483-2023 on September 6, 2023. Reported hazard: Their is a potential that optical devices with insufficient anti-reflective coating may lead to incorrect axial length measurements.

What should I do if I have this product?

Voluntary: Firm initiated · Letter